| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 41 | 37 | 36 | 36 | 41 | 43 | 41 | 39 | 45 | 44 | 68 | 98 | 101 | 84 | 131 | 113 | 93 | 84 | 86 | 70 | 67 | 96 | 95 | 91 | 104 | 112 | 102 | 94 | 99 | 96 | 101 | 55 | 106 | 85 | 59 | 102 | 103 | 81 | 98 | 159 | 144 | 145 | 136 | 141 | 136 |
| Expenses | 34 | 32 | 33 | 33 | 38 | 35 | 41 | 38 | 39 | 42 | 50 | 59 | 59 | 54 | 77 | 67 | 61 | 57 | 65 | 53 | 55 | 72 | 66 | 68 | 89 | 84 | 84 | 91 | 78 | 87 | 95 | 84 | 95 | 72 | 78 | 74 | 92 | 77 | 76 | 103 | 103 | 108 | 104 | 115 | 102 |
| EBITDA | 7 | 5 | 3 | 4 | 3 | 8 | 1 | 1 | 6 | 2 | 18 | 40 | 43 | 29 | 54 | 46 | 32 | 27 | 21 | 17 | 12 | 24 | 29 | 23 | 15 | 28 | 18 | 3 | 21 | 9 | 6 | -29 | 11 | 13 | -19 | 28 | 11 | 4 | 22 | 56 | 41 | 37 | 32 | 26 | 34 |
| Operating Profit % | 17 % | 14 % | 10 % | 10 % | 6 % | 18 % | -1 % | -1 % | 12 % | 4 % | 21 % | 40 % | 39 % | 32 % | 37 % | 40 % | 34 % | 30 % | 19 % | 21 % | 15 % | 24 % | 29 % | 25 % | 10 % | 24 % | 16 % | 2 % | 18 % | 5 % | 3 % | -53 % | 10 % | 13 % | -38 % | 25 % | 6 % | 1 % | 20 % | 34 % | 26 % | 21 % | 20 % | 17 % | 16 % |
| Depreciation | 1 | 2 | 2 | 2 | 3 | 2 | 3 | 3 | 3 | 3 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 4 | 4 | 4 | 4 | 4 | 5 | 5 | 6 | 6 | 6 | 7 | 7 | 7 | 9 | 6 | 6 | 6 | 6 | 6 | 7 | 6 | 6 | 6 | 6 | 6 | 5 | 5 | 5 |
| Interest | 1 | 1 | 1 | 1 | 3 | 3 | 3 | 2 | 3 | 3 | 4 | 2 | 4 | 4 | 5 | 6 | 6 | 5 | 5 | 5 | 4 | 4 | 5 | 4 | 5 | 4 | 4 | 4 | 4 | 5 | 5 | 5 | 6 | 5 | 4 | 5 | 3 | 3 | 4 | 4 | 3 | 3 | 3 | 3 | 3 |
| Profit Before Tax | 5 | 3 | 3 | 2 | -1 | 3 | -5 | -4 | 0 | -3 | 11 | 34 | 35 | 22 | 46 | 37 | 23 | 19 | 12 | 8 | 4 | 16 | 18 | 14 | 3 | 18 | 7 | -7 | 10 | -2 | -8 | -41 | -1 | 2 | -29 | 16 | 1 | -6 | 12 | 45 | 32 | 28 | 24 | 18 | 26 |
| Tax | 2 | 1 | 2 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 4 | 8 | 17 | 5 | 12 | 10 | -15 | 5 | -21 | -2 | 1 | 2 | 4 | 4 | -1 | 6 | 3 | 1 | 2 | 0 | 1 | -3 | 4 | 0 | 0 | 6 | 8 | 0 | 1 | 8 | -1 | 7 | 6 | 6 | 8 |
| Net Profit | 3 | 2 | 1 | 1 | -2 | 2 | -6 | -4 | -1 | -4 | 7 | 26 | 18 | 17 | 35 | 28 | 39 | 14 | 33 | 10 | 3 | 14 | 15 | 10 | 4 | 12 | 4 | -8 | 8 | -3 | -9 | -38 | -5 | 2 | -29 | 10 | -7 | -6 | 11 | 38 | 33 | 22 | 18 | 12 | 19 |
| EPS in ₹ | 9.93 | 5.63 | 0.93 | 1.41 | -12.92 | 8.68 | -25.39 | -18.97 | -8.84 | -17.57 | 29.17 | 82.73 | 17.38 | 72.32 | 34.84 | 9.68 | 13.33 | 14.21 | 33.99 | 3.35 | 1.09 | 4.72 | 5.10 | 3.40 | 2.56 | 3.92 | 1.56 | -2.79 | 2.66 | -0.90 | -2.80 | -12.97 | -1.42 | 0.64 | -7.32 | 3.41 | -2.41 | -2.01 | 3.94 | 12.71 | 11.79 | 7.49 | 6.20 | 4.36 | 6.66 |
Fermenta Biotech
Fermenta Biotech
432.05
+31.05
(7.74%)
Market Cap
1,271.57 Cr
PE Ratio
16.84
Volume
2,13,384.00
Day High - Low
435.40 - 395.15
52W High-Low
479.45 - 248.85
Key Fundamentals
Market Cap
1,271.57 Cr
EPS
24.70
PE Ratio
16.84
PB Ratio
2.91
Book Value
138.15
EBITDA
122.20
Dividend Yield
0.91 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
17.54
Debt to Equity
0.30
Actual
Company News
View All News
Fermenta Biotech Limited has announced a one-to-one physical investor meeting scheduled for July 29, 2026, in Mumbai. The company confirmed that no unpublished price-sensitive information will be shared during the interaction.
Fermenta Biotech filed its Business Responsibility and Sustainability Report for FY 2025-26. Exports contributed 58% of total turnover.
Fermenta Biotech Limited has scheduled its 74th AGM for August 11, 2026, to approve financial statements and a dividend of ₹3.75 per share. The meeting will also seek shareholder approval for related party transactions and director remuneration.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,941.10 | #1 4,65,734.91 | 40.73 | #1 61,673.90 | 12.69 | #1 11,565 | 25.80 | 59.45 | |
7,248.50 | 1,92,424.90 | 75.49 | 11,067.00 | 13.95 | 2,568 | 13.44 | 63.62 | |
4,961.50 | 1,88,719.51 | 90.12 | 13,886.20 | 20.34 | 2,138 | -26.91 | 59.29 | |
1,410.60 | 1,13,954.66 | 33.55 | 29,044.60 | 2.24 | 3,870 | -39.18 | 46.84 | |
1,108.70 | 1,11,561.16 | 21.68 | 27,657.90 | 17.64 | 5,026 | 7.82 | 46.17 | |
2,370.50 | 1,08,386.97 | #1 20.46 | 29,038.90 | #1 26.75 | 5,356 | #1 87.72 | 43.65 | |
2,507.20 | 1,03,546.35 | 54.49 | 14,636.40 | 14.85 | 1,938 | 31.75 | 50.58 | |
1,151.70 | 96,128.84 | 30.58 | 35,058.60 | 3.90 | 4,158 | -69.10 | 25.61 | |
1,532.00 | 88,147.89 | 25.27 | 33,384.70 | 3.21 | 3,376 | 1.99 | 49.37 | |
1,601.20 | 86,441.84 | 95.16 | 6,867.80 | 22.01 | 890 | 21.18 | 66.26 |
Growth Rate
Revenue Growth
13.82 %
Net Income Growth
-7.98 %
Cash Flow Change
126.97 %
ROE
-17.69 %
ROCE
1.12 %
EBITDA Margin (Avg.)
-11.71 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 262 | 288 | 308 | 387 | 551 | 614 | 687 | 707 | 637 | 548 | 615 | 648 |
| Fixed Assets | 85 | 168 | 172 | 177 | 178 | 200 | 263 | 299 | 267 | 269 | 227 | 220 |
| Current Assets | 91 | 95 | 104 | 182 | 296 | 284 | 310 | 314 | 253 | 242 | 335 | 388 |
| Capital Work in Progress | 65 | 6 | 6 | 4 | 22 | 71 | 57 | 35 | 45 | 2 | 16 | 13 |
| Investments | 3 | 1 | 18 | 12 | 8 | 0 | 0 | 0 | 3 | 0 | 1 | 0 |
| Other Assets | 109 | 113 | 113 | 194 | 344 | 343 | 367 | 373 | 321 | 277 | 372 | 414 |
| Total Equity & Liabilities | 262 | 288 | 308 | 387 | 551 | 614 | 687 | 707 | 637 | 548 | 615 | 648 |
| Current Liabilities | 94 | 109 | 86 | 104 | 156 | 195 | 209 | 207 | 209 | 173 | 212 | 209 |
| Non Current Liabilities | 14 | 24 | 49 | 146 | 145 | 110 | 117 | 128 | 115 | 89 | 44 | 39 |
| Total Equity | 154 | 156 | 173 | 137 | 251 | 309 | 360 | 372 | 313 | 285 | 359 | 401 |
| Reserve & Surplus | 129 | 128 | 142 | 124 | 246 | 295 | 346 | 358 | 301 | 274 | 348 | 392 |
| Share Capital | 2 | 2 | 2 | 2 | 5 | 14 | 14 | 14 | 14 | 14 | 15 | 14 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
| Net Cash Flow | -2 | 2 | -4 | 47 | 6 | -57 | 21 | -4 | 19 | -1 | -10 | 8 |
| Investing Activities | -18 | -13 | 7 | -101 | -97 | -44 | -41 | -26 | -55 | -16 | -0 | -43 |
| Operating Activities | 15 | 4 | 2 | 59 | 90 | 35 | 63 | 43 | 116 | 105 | 41 | 93 |
| Financing Activities | 1 | 10 | -12 | 89 | 12 | -48 | -1 | -22 | -41 | -91 | -51 | -42 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| Promoter | 59.44 % | 59.44 % | 59.44 % | 59.58 % | 59.58 % | 59.58 % | 59.58 % | 59.58 % | 59.58 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 62.06 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % | 64.09 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.05 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.13 % |
| DIIs | 0.24 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.05 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.04 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 32.86 % | 32.33 % | 33.17 % | 33.98 % | 33.86 % | 33.98 % | 34.06 % | 34.12 % | 33.99 % | 32.28 % | 32.37 % | 32.56 % | 32.47 % | 32.51 % | 31.29 % | 32.31 % | 30.38 % | 29.60 % | 29.76 % | 29.48 % | 28.80 % | 28.33 % |
| Others | 7.45 % | 8.22 % | 7.39 % | 6.43 % | 6.55 % | 6.43 % | 6.30 % | 6.29 % | 6.42 % | 5.66 % | 5.57 % | 5.38 % | 5.47 % | 5.43 % | 6.59 % | 5.60 % | 5.51 % | 6.29 % | 6.12 % | 6.41 % | 7.09 % | 7.42 % |
| No of Share Holders | 15,027 | 15,541 | 18,399 | 18,578 | 17,518 | 17,472 | 17,971 | 17,610 | 16,897 | 16,148 | 15,721 | 15,150 | 15,178 | 14,589 | 13,221 | 12,922 | 12,930 | 12,845 | 13,760 | 14,139 | 13,661 | 14,131 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.75 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.87 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 11 Aug 2026 |  Annual General Meeting | NA | 11 Aug 2026 | 304.35 | 432.05 |
| 05 Aug 2026 |  Dividend | ₹ 3.75 /share | 05 Aug 2026 | 304.35 | 432.05 |
| 05 Nov 2019 |  Change Of Name | NA | 05 Nov 2019 | 234.96 | 234.96 |
| 14 Feb 2020 |  Bonus | 2:1 | 13 Feb 2020 | 239.30 | 276.10 |
| 27 Aug 2021 | Dividend | ₹ 2.50 /share | 25 Aug 2021 | 331.25 | 288.70 |
| 05 Aug 2022 | Dividend | ₹ 1.25 /share | 04 Aug 2022 | 198.80 | 191.30 |
| 02 Sept 2022 |  Extraordinary General Meeting | NA | 02 Sept 2022 | 193.20 | 183.15 |
| 22 Sept 2023 | Dividend | ₹ 1.25 /share | 22 Sept 2023 | 142.65 | 170.55 |
| 06 Aug 2024 | Dividend | ₹ 1.25 /share | 06 Aug 2024 | 166.90 | 243.70 |
| 12 Aug 2024 | Annual General Meeting | NA | 12 Aug 2024 | 166.90 | 253.90 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 337.75 | 320.45 |
| 11 Feb 2025 | Quarterly Result Announcement | NA | 11 Feb 2025 | 372.85 | 416.85 |
| 28 May 2025 | Quarterly Result Announcement | NA | 28 May 2025 | 299.95 | 294.05 |
| 06 Aug 2025 | Dividend | ₹ 2.50 /share | 06 Aug 2025 | 294.05 | 360.00 |
| 12 Aug 2025 | Annual General Meeting | NA | 12 Aug 2025 | 294.05 | 346.10 |
| 12 Aug 2025 | Quarterly Result Announcement | NA | 12 Aug 2025 | 356.10 | 346.10 |
| 11 Nov 2025 | Quarterly Result Announcement | NA | 11 Nov 2025 | 267.30 | 277.30 |
| 09 Feb 2026 | Quarterly Result Announcement | NA | 09 Feb 2026 | 328.90 | 328.25 |
| 26 May 2026 | Quarterly Result Announcement | NA | 26 May 2026 | 288.35 | 304.35 |
Announcements
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
2 days ago
2 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication5 days ago
5 days agoBusiness Responsibility and Sustainability Reporting (BRSR)6 days ago
6 days agoNotice Of The 74Th Annual General Meeting Of Fermenta Biotech Limited To Be Held On August 11 2026.6 days ago
6 days agoReg. 34 (1) Annual Report.6 days ago
6 days agoCessation Of Subsidiary Viz. Fermenta Environment Solutions Private Limited Being A Wholly-Owned Subsidiary.6 days ago
6 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation9 days ago
9 days agoClarification On Price Movement In The CompanyS Shares.9 days ago
9 days agoClarification sought from Fermenta Biotech Ltd10 days ago
10 days agoAnnouncement under Regulation 30 (LODR)-Newspaper Publication10 days ago
10 days agoCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 15, 2026
Jul 15, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 06, 2026
Jul 06, 2026Approval From Food Safety And Standards Authority Of India (FSSAI) For CompanyS Product Vitamin D3 (Cholecalciferol) - Plant Source.Jul 03, 2026
Jul 03, 2026Closure of Trading WindowJun 29, 2026
Jun 29, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJun 25, 2026
Jun 25, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 24, 2026
Jun 24, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 22, 2026
Jun 22, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2026
Jun 17, 2026Application To National Stock Exchange Of India Limited For Seeking Approval For Listing And Trading Of The CompanyS Equity Shares.Jun 16, 2026
Jun 16, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 15, 2026
Jun 15, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 09, 2026
Jun 09, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 08, 2026
Jun 08, 2026Announcement under Regulation 30 (LODR)-Investor PresentationMay 28, 2026
May 28, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 27, 2026
May 27, 2026Corporate Action-Board approves DividendMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 26, 2026
May 26, 2026Intimation Under Regulation 30 And Other Applicable Provisions Of SEBI Listing RegulationsMay 26, 2026
May 26, 2026Board Meeting Outcome for Annual General Meeting Financial Results And DividendMay 26, 2026
May 26, 2026Audited Financial Statements (Standalone And Consolidated) For Quarter & Year Ended March 31 2026 Along With Auditors Report Thereon Along With Information For AGM And DividendMay 26, 2026
May 26, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 25, 2026
May 25, 2026Board Meeting Intimation for Audited Financial Results Of The Company For The Quarter And Financial Year Ended March 31 2026 And Consideration Of Final Equity Dividend If Any.May 19, 2026
May 19, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 07, 2026
May 07, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 28, 2026
Apr 28, 2026Format of the Annual Disclosure to be made by an entity identified as a LC - Annexure B2Apr 28, 2026
Apr 28, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 28, 2026
Apr 28, 2026Admission Of Companys Shares By NSE Under Permitted To Trade Category On National Stock Exchange (Capital Market Segment).Apr 21, 2026
Apr 21, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2026
Apr 15, 2026Closure of Trading WindowMar 31, 2026
Mar 31, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 28, 2026
Feb 28, 2026Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 19, 2026
Feb 19, 2026Intimation Of Investor Presentation - Q3/9Mofy26Feb 11, 2026
Feb 11, 2026Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 10, 2026
Feb 10, 2026Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 09, 2026
Feb 09, 2026Board Meeting Outcome for Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Feb 09, 2026
Feb 09, 2026Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025.Feb 09, 2026
Feb 09, 2026Board Meeting Intimation for Unaudited Financial Results For Quarter And Nine Months Ended December 31 2025.Feb 02, 2026
Feb 02, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 21, 2026
Jan 21, 2026Announcement under Regulation 30 (LODR)-Award_of_Order_Receipt_of_OrderDec 31, 2025
Dec 31, 2025Closure of Trading WindowDec 29, 2025
Dec 29, 2025Mutual Fund Holdings
| Funding House | Current Holding % | 1M Change | 1M Change % | 3M Change % | Last 6M Trend |
|---|---|---|---|---|---|
 Bandhan BSE Healthcare Index Fund Direct-Growth | 0.02% | 0 | 0.00% | 0.00% |
Technical Indicators
RSI(14)
Neutral 59.63
ATR(14)
Volatile 26.31
STOCH(9,6)
Neutral 47.63
STOCH RSI(14)
Oversold 17.12
MACD(12,26)
Bearish -2.28
ADX(14)
Strong Trend 29.82
UO(9)
Bearish 49.02
ROC(12)
Uptrend And Accelerating 18.92
WillR(14)
Neutral -36.10
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
